THE ASSOCIATION OF ALDOSTERONE-PRODUCING ADRENAL ADENOMA IN A PATIENT WITH AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE

被引：3
|
作者：
LIOU, HH [1 ]
TSAI, SC [1 ]
CHEN, WJ [1 ]
HUANG, TP [1 ]
HUANG, WJS [1 ]
CHEN, KK [1 ]
机构：
[1] VET GEN HOSP,DEPT SURG,UROL SECT,TAIPEI 11217,TAIWAN
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 1994年 / 23卷 / 05期
关键词：
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE; ADRENAL ADENOMA;
D O I：
10.1016/S0272-6386(12)70287-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We report a young female with autosomal dominant polycystic kidney disease associated with right adrenal adenoma. Refractory hypertension and hypokalemia were the findings that led to this diagnosis. The diagnostic approach included plasma potassium and aldosterone levels, plasma renin activity, captopril test, saline infusion test, NP-59 scintigraphy, computed tomography, and magnetic resonance imaging. Adrenalectomy completely normalized hypertension and hypokalemia in this patient. © 1994, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码：739 / 742
页数：4
相关论文
共 50 条
  • [21] AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE IN BLACKS - CLINICAL COURSE AND EFFECTS OF SICKLE-CELL HEMOGLOBIN
    YIUM, J
    GABOW, P
    JOHNSON, A
    KIMBERLING, W
    MARTINEZMALDONADO, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 4 (09): : 1670 - 1674
  • [22] VALUE OF MAGNETIC-RESONANCE ANGIOGRAPHY FOR THE DETECTION OF INTRACRANIAL ANEURYSMS IN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE
    HUSTON, J
    TORRES, VE
    SULIVAN, PP
    OFFORD, KP
    WIEBERS, DO
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 3 (12): : 1871 - 1877
  • [23] Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease
    Oflaz, H
    Alisir, S
    Buyukaydin, B
    Kocaman, O
    Turgut, F
    Namli, S
    Pamukcu, B
    Oncul, A
    Ecder, T
    KIDNEY INTERNATIONAL, 2005, 68 (05) : 2244 - 2249
  • [24] Metabolic Syndrome Components in Patients with Autosomal-Dominant Polycystic Kidney Disease
    Pietrzak-Nowacka, Maria
    Safranow, Krzysztof
    Byra, Elzbieta
    Binczak-Kuleta, Agnieszka
    Ciechanowicz, Andrzej
    Ciechanowski, Kazimierz
    KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (06) : 405 - 410
  • [25] Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease
    Rodney D. Gilbert
    Hazel Evans
    Kazeem Olalekan
    Arvind Nagra
    Mushfequr R. Haq
    Mark Griffiths
    Pediatric Nephrology, 2017, 32 : 893 - 896
  • [26] Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease
    Gilbert, Rodney D.
    Evans, Hazel
    Olalekan, Kazeem
    Nagra, Arvind
    Haq, Mushfequr R.
    Griffiths, Mark
    PEDIATRIC NEPHROLOGY, 2017, 32 (05) : 893 - 896
  • [27] Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease
    Helal, Imed
    McFann, Kim
    Reed, Berenice
    Yan, Xiang-Dong
    Schrier, Robert W.
    Fick-Brosnahan, Godela M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (02) : 380 - 385
  • [28] A comparative study of three kidney biomarker tests in autosomal-dominant polycystic kidney disease
    Casal, JA
    Hermida, J
    Lens, XM
    Tutor, JC
    KIDNEY INTERNATIONAL, 2005, 68 (03) : 948 - 954
  • [29] Screening for Intracranial Aneurysm in 355 Patients With Autosomal-Dominant Polycystic Kidney Disease
    Xu, H. W.
    Yu, Sheng Qiang
    Mei, Chang Lin
    Li, Ming Hua
    STROKE, 2011, 42 (01) : 204 - 206
  • [30] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE - FROM MOLECULAR-GENETICS TO THE PATIENTS
    GRUNFELD, JP
    CHAUVEAU, D
    KNEBELMANN, B
    CLINICAL INVESTIGATOR, 1992, 70 (09): : 791 - 793
12345